BioSpace News Archive

Business

Orig3n Announces Collaboration with Researchers at Harvard University

Orig3n, a Boston-based biotech company, today announced a research collaboration agreement with Harvard University, led by a faculty member from the Harvard Stem Cell Institute (HSCI), to develop cell therapies for the treatment of cardiovascular disease.

October 2, 2018
·
2 min read
Business

The Founder and CEO of Samuel Waxman Cancer Research Foundation Receives China’s Highest Honor Granted to a Foreigner

The Samuel Waxman Cancer Research Foundation (SWCRF), an international nonprofit organization that funds cutting-edge cancer research, today announced that its founder and CEO, Samuel Waxman, M.D. received China’s highest honor granted to a foreigner.

October 2, 2018
·
2 min read
Business

Premier Biomedical, Inc. Discusses CBD Public Image Challenges and the Future Marketplace with Uptick Newswire’s Stock Day Podcast

CEO and President of Premier Biomedical, Inc., William A. Hartman, talked with Stock Day’s Everett Jolly about recent issues facing his industry and company.

October 2, 2018
·
6 min read
Pharm Country

Pareteum Adds $15 Million in New Contracts

Platform as a Service Unleashes Multiple Use Cases

October 2, 2018
·
4 min read
Business

Kite and HiFiBiO Therapeutics Announce a Research Collaboration to Develop Technology for the Potential Discovery of Neoantigen-Reactive T Cell Receptors (TCRs) for the Treatment of Cancer

Agreement to develop technology supporting the discovery of neoantigen-reactive T cell receptors (TCRs) for the potential treatment of various cancers, including solid tumors.

October 2, 2018
·
4 min read
Deals

Democrasales and Grogan’s Complete Acquisition of eMed Healthcare

eMed is a leading supplier of medical supplies and emergency medical equipment to EMS, physician offices, dental offices, surgery centers, hospitals, hotels, public services, fire departments, police departments and other first responders. Financial terms of the transaction are not being disclosed.

October 2, 2018
·
1 min read
FDA

FDA Approves SEYSARA™ (Sarecycline) for the Treatment of Moderate to Severe Acne

To be launched in U.S. by Almirall SA

October 2, 2018
·
3 min read
BioCapital

The Lieber Institute for Brain Development Announces Nomination Period for the 2019 Constance Lieber Prize for Innovation in Developmental Neuroscience

The Lieber Institute for Brain Development (LIBD), an affiliate of the Johns Hopkins School of Medicine, announced today the nomination period for the 2019 Constance Lieber Prize for Innovation in Developmental Neuroscience is officially open.

October 2, 2018
·
2 min read
Pharm Country

North American Legal Cannabis Market Set to Grow as Production Capabilities Increase

According to data from IMARC, the legal cannabis market in North America was valued at USD 8 Billion in 2017 and is expected to reach USD 35 Billion by 2023 while growing at a compound annual growth rate (CAGR) of 28% during the forecast years.

October 2, 2018
·
12 min read
Pharm Country

Research Projects the U.S. Medical Cannabis Market to Reach USD 12.5 Billion by 2025

According to a report from New Frontier Data, the U.S. legal cannabis market is expected to grow at a compound annual growth rate (CAGR) of 14.7% to USD 25 Billion by 2025.

October 2, 2018
·
12 min read